RARE ACCESS ACTION PROJECT

Lobbying Spend

—

Filings

Firms Hired

Active Period

2018–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	2
2025	—	8	2
2024	—	8	2
2023	—	15	4
2022	—	8	2
2021	—	8	2
2020	—	8	2
2019	—	8	2
2018	—	5	2

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
COMMONWEALTH POLICY SOLUTIONS	—	32
UPSTREAM CONSULTING, INC.	—	33
MJS ADVISORS LLC	—	4
ERVIN GRAVES STRATEGY GROUP, LLC	—	3

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	68
SENATE	68

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	66
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	49
Health Issues	Health Issues	43
Budget/Appropriations	Budget/Appropriations	2

RARE ACCESS ACTION PROJECT — Lobbying Disclosure | Poliscope